Agilent Technologies said today that it has acquired Halo Genomics, a privately held Uppsala, Sweden-based provider of sample prep tools for next-generation sequencing.

According to Agilent, the acquisition of Halo and its HaloPlex target enrichment technology will help accelerate Agilent's entry into the next-generation clinical sequencing market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.